ATE524191T1 - Topische pharmazeutische zusammensetzungen für die vagina - Google Patents

Topische pharmazeutische zusammensetzungen für die vagina

Info

Publication number
ATE524191T1
ATE524191T1 AT07013448T AT07013448T ATE524191T1 AT E524191 T1 ATE524191 T1 AT E524191T1 AT 07013448 T AT07013448 T AT 07013448T AT 07013448 T AT07013448 T AT 07013448T AT E524191 T1 ATE524191 T1 AT E524191T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
vagina
topical pharmaceutical
topical
rhatany
Prior art date
Application number
AT07013448T
Other languages
English (en)
Inventor
Pierro Francesco Di
Original Assignee
Velleja Res Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velleja Res Srl filed Critical Velleja Res Srl
Application granted granted Critical
Publication of ATE524191T1 publication Critical patent/ATE524191T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07013448T 2006-07-20 2007-07-09 Topische pharmazeutische zusammensetzungen für die vagina ATE524191T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001421A ITMI20061421A1 (it) 2006-07-20 2006-07-20 Composizioni farmaceutiche topiche vaginali

Publications (1)

Publication Number Publication Date
ATE524191T1 true ATE524191T1 (de) 2011-09-15

Family

ID=38872008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07013448T ATE524191T1 (de) 2006-07-20 2007-07-09 Topische pharmazeutische zusammensetzungen für die vagina

Country Status (5)

Country Link
EP (1) EP1880727B1 (de)
AT (1) ATE524191T1 (de)
DK (1) DK1880727T3 (de)
IT (1) ITMI20061421A1 (de)
NO (1) NO20073757L (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011254804A1 (en) * 2010-05-18 2012-12-06 Indena S.P.A. Compositions for the treatment of gynaecological disorders
JP6990922B2 (ja) 2015-05-11 2022-01-12 マイバイオティクス ファーマ リミテッド 腸における細菌のコロニー形成のために固体粒子上で生菌のバイオフィルムを成長させるためのシステムおよび方法
DE202015106259U1 (de) * 2015-11-10 2016-11-11 Tina Ströer Neuartiger Hygieneartikel
IL263218B (en) 2016-05-25 2022-07-01 Mybiotics Pharma Ltd Composition and methods for microbiota therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections

Also Published As

Publication number Publication date
ITMI20061421A1 (it) 2008-01-21
DK1880727T3 (da) 2011-11-28
EP1880727A3 (de) 2010-03-24
EP1880727A2 (de) 2008-01-23
NO20073757L (no) 2008-01-21
EP1880727B1 (de) 2011-09-14

Similar Documents

Publication Publication Date Title
AR114143A2 (es) Formulaciones de comprimidos revestidos
EP2033688A3 (de) Oxalsäurederivate und deren Verwendung als physiologische Kühlwirkstoffe
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
UY31526A1 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
DOP2007000102A (es) Arilimidazolonas y ariltriazolona sustituidas asi como su uso
BR112012010057A2 (pt) ácido 3-fenilpropiônico substituído e sua aplicação.
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
HN2009000784A (es) Dihidropirazolonas sustituidas
AR064830A1 (es) Composiciones para el cuidado oral que comprenden un extracto de hippophae
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
SI2432798T1 (sl) Derivat 17-hidroksi-17-pentafluoretil-estra-4,9(10)-dien-11-arila, postopki izdelave in uporaba pri zdravljenju bolezni
EP2153831A4 (de) Antiermüdungsmittel und orale zusammensetzung, beide mit andrographolid als wirkstoff
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
BRPI0918876A2 (pt) composições para a profilaxia e tratamento de doença dermatológica/mucosa, e suas utilizações
BRPI0910737A2 (pt) composto, pró-droga, agente farmacêutico, método para profilaxia ou tratamento de doenças do trato urinário inferior em um mamífero, e, uso de um composto ou uma pró-droga do mesmo.
CR10092A (es) Nuevos derivados de furopirimidina aciclicos sustituidos y su uso
EP4410369A3 (de) Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
ATE524191T1 (de) Topische pharmazeutische zusammensetzungen für die vagina
WO2007083190A8 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
ATE531715T1 (de) 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
PL1829548T3 (pl) Zastosowanie ekstraktów z Pelargonium w połączeniu z Plantago do wytwarzania środka leczniczego do leczenia zapalenia gardła

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties